This 2009 hypothesis paper by Daniel J. Cameron critically examines the limitations of existing evidence used to deny antibiotic therapy for chronic Lyme disease (CLD). The author identifies eight key limitations, including inadequate study power, heterogeneity of data, unaddressed risks of long-term illness, and lack of consideration for co-infections and
This 2005 prospective, open-label, randomized, multicenter trial compared 14-day versus 28-day intravenous ceftriaxone regimens in 143 serologically confirmed patients with late Lyme disease. Clinical cure rates were 76% for the 14-day group and 70% for the 28-day group (p = NS). While there were more treatment failures in the 14-day
This 2007 review discusses Small Intestinal Bacterial Overgrowth (SIBO), a condition characterized by excessive bacteria in the small intestine leading to malabsorption and symptoms like diarrhea, steatorrhea, abdominal pain, bloating, and flatulence. The article highlights that SIBO results from failures in mechanisms that usually prevent bacterial colonization, such as gastric
This 2018 review examines Small Intestinal Bacterial Overgrowth (SIBO), a condition characterized by excessive bacteria in the small intestine, leading to symptoms like bloating, diarrhea, and malabsorption. The article discusses the challenges in diagnosing SIBO due to the lack of a gold standard, with current methods including breath tests and
This 2013 review discusses trimethylaminuria (TMAU), commonly known as fish odor syndrome, a rare metabolic disorder characterized by a strong, unpleasant body odor resembling that of rotting fish. The condition is primarily caused by a deficiency in the hepatic enzyme flavin-containing monooxygenase 3 (FMO3), which is responsible for converting trimethylamine
